Management of chemotherapy-resistant breast cancer

被引：1

作者：

Miles, DW

Rubens, RD

机构：

来源：

BREAST | 1996年 / 5卷 / 04期

关键词：

D O I：

10.1016/S0960-9776(96)90028-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The second workshop of the European School of Oncology Task Force Programme on Breast Cancer Management of Chemotherapy-Resistant Disease took place in London on 10-11 November 1995. The first workshop focused on the problems of anthracycline resistant disease and highlighted the need for operational definitions of anthracycline resistance when comparing novel approaches.' The purpose of the present workshop was to appraise further the problem of chemoresistant breast cancer and examine the prospects for circumventing drug resistance.

引用

收藏

页码：288 / 292

页数：5

相关论文

共 29 条

[1] RETRACTED: HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC RESCUE AS PRIMARY-TREATMENT FOR METASTATIC BREAST-CANCER - A RANDOMIZED TRIAL (Retracted article. See vol. 19, pg. 2973, 2001) [J].

BEZWODA, WR ;

SEYMOUR, L ;

DANSEY, RD .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2483-2489

[2] INCREASED ACCUMULATION OF P53 PROTEIN IN CISPLATIN-RESISTANT OVARIAN CELL-LINES [J].

BROWN, R ;

CLUGSTON, C ;

BURNS, P ;

EDLIN, A ;

VASEY, P ;

VOJTESEK, B ;

KAYE, SB .

INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (04) :678-684

[3]

CARDARELLI CO, 1995, CANCER RES, V55, P1086

[4] TOPOISOMERASE-I INHIBITORS - TOPOTECAN AND IRENOTECAN [J].

CREEMERS, GJ ;

LUND, B ;

VERWEIJ, J .

CANCER TREATMENT REVIEWS, 1994, 20 (01) :73-96

[5] ACCUMULATION OF P53 PROTEIN AS A POSSIBLE PREDICTOR OF RESPONSE TO ADJUVANT COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, FLUOROURACIL, AND PREDNISONE FOR BREAST-CANCER [J].

ELLEDGE, RM ;

GRAY, R ;

MANSOUR, E ;

YU, YY ;

CLARK, GM ;

RAVDIN, P ;

OSBORNE, CK ;

GILCHRIST, K ;

DAVIDSON, NE ;

ROBERT, N ;

TORMEY, DC ;

ALLRED, DC .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (16) :1254-1256

[6] THE INFLUENCE OF ANGIOGENESIS RESEARCH ON MANAGEMENT OF PATIENTS WITH BREAST-CANCER [J].

FOLKMAN, J .

BREAST CANCER RESEARCH AND TREATMENT, 1995, 36 (02) :109-118

[7]

GASPARINI G, 1995, CLIN CANCER RES, V1, P189

[8] PACLITAXEL BY 3-HOUR INFUSION IN COMBINATION WITH BOLUS DOXORUBICIN IN WOMEN WITH UNTREATED METASTATIC BREAST-CANCER - HIGH ANTITUMOR EFFICACY AND CARDIAC EFFECTS IN A DOSE-FINDING AND SEQUENCE-FINDING STUDY [J].

GIANNI, L ;

MUNZONE, E ;

CAPRI, G ;

FULFARO, F ;

TARENZI, E ;

VILLANI, F ;

SPREAFICO, C ;

LAFFRANCHI, A ;

CARACENI, A ;

MARTINI, C ;

STEFANELLI, M ;

VALAGUSSA, P ;

BONADONNA, G .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) :2688-2699

[9]

GOGAS H, IN PRESS CANC TREAT

[10] CHEMOTHERAPY OF ADVANCED BREAST-CANCER - OUTCOME AND PROGNOSTIC FACTORS [J].

GREGORY, WM ;

SMITH, P ;

RICHARDS, MA ;

TWELVES, CJ ;

KNIGHT, RK ;

RUBENS, RD .

BRITISH JOURNAL OF CANCER, 1993, 68 (05) :988-995